| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.4 | 0.04 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.34 | 0.08 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.33 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.004 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.22 | 0.3 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.21 | 0.3 |